Blog
FTI Consulting (FCN) Surpasses Q4 Earnings and Revenue Estimates
FTI Consulting (FCN) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.39 per share. This compares to earnings of $1.56 per share a year ago. These
Shift4 Payments (FOUR) Q4 Earnings Surpass Estimates
Shift4 Payments (FOUR) came out with quarterly earnings of $1.6 per share, beating the Zacks Consensus Estimate of $1.57 per share. This compares to earnings of $1.35 per share a year ago. These
Emcor Group (EME) Q4 Earnings and Revenues Top Estimates
Emcor Group (EME) came out with quarterly earnings of $7.19 per share, beating the Zacks Consensus Estimate of $6.68 per share. This compares to earnings of $6.32 per share a year ago. These figures
Cars.com (CARS) Misses Q4 Earnings Estimates
Cars.com (CARS) came out with quarterly earnings of $0.44 per share, missing the Zacks Consensus Estimate of $0.56 per share. This compares to earnings of $0.49 per share a year ago. These figures
Burford Capital Limited (BUR) Reports Q4 Loss, Misses Revenue Estimates
Burford Capital Limited (BUR) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of $0.37. This compares to a loss of $0.06 per share a year ago. These figures are
Collegium Pharmaceutical (COLL) Q4 Earnings and Revenues Miss Estimates
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $2.04 per share, missing the Zacks Consensus Estimate of $2.19 per share. This compares to earnings of $1.77 per share a year ago
CRA International (CRAI) Q4 Earnings and Revenues Beat Estimates
CRA International (CRAI) came out with quarterly earnings of $2.06 per share, beating the Zacks Consensus Estimate of $2.05 per share. This compares to earnings of $2.03 per share a year ago. These
Anika Therapeutics (ANIK) Q4 Earnings and Revenues Beat Estimates
Anika Therapeutics (ANIK) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to a loss of $0.03 per share a year ago. These
ACM Research, Inc. (ACMR) Lags Q4 Earnings Estimates
ACM Research, Inc. (ACMR) came out with quarterly earnings of $0.25 per share, missing the Zacks Consensus Estimate of $0.39 per share. This compares to earnings of $0.56 per share a year ago. These
BlackSky Technology Inc. (BKSY) Reports Q4 Loss, Lags Revenue Estimates
BlackSky Technology Inc. (BKSY) came out with a quarterly loss of $0.19 per share versus the Zacks Consensus Estimate of a loss of $0.25. This compares to a loss of $0.39 per share a year ago. These
BioCryst Pharmaceuticals (BCRX) Q4 Earnings and Revenues Surpass Estimates
BioCryst Pharmaceuticals (BCRX) came out with quarterly earnings of $1.12 per share, beating the Zacks Consensus Estimate of $0.07 per share. This compares to a loss of $0.13 per share a year ago
Why Heritage Insurance (HRTG) Could Beat Earnings Estimates Again
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Heritage Insurance (HRTG), which belongs
2 Home Furnishing Stocks Set to Benefit Despite Industry Odds
Ross Stores Stock Shows Momentum Before Q4 Results: Is a Beat Likely?
Ross Stores, Inc. ROST is likely to post year-over-year top and bottom line growth when it reports fourth-quarter fiscal 2025 earnings on March 3, after market close. The Zacks Consensus Estimate
Alexander's (ALX) Upgraded to Buy: Here's What You Should Know
Alexander's (ALX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting
Okta (OKTA) Upgraded to Strong Buy: Here's What You Should Know
Okta (OKTA) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one
Super Group (SGHC) (SGHC) Upgraded to Strong Buy: Here's What You Should Know
Investors might want to bet on Super Group (SGHC) Limited (SGHC), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful
EDENRED (EDNMY) Upgraded to Buy: What Does It Mean for the Stock?
EDENRED (EDNMY) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of
Fluor (FLR) is a Great Momentum Stock: Should You Buy?
Momentum investing revolves around the idea of following a stock's recent trend in either direction. In "long context," investors will be essentially be "buying high, but hoping to sell even
Boot Barn (BOOT) Upgraded to Strong Buy: Here's What You Should Know
Boot Barn (BOOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces
What Makes Sasol (SSL) a Strong Momentum Stock: Buy Now?
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
Haleon PLC Sponsored ADR (HLN) Moves to Buy: Rationale Behind the Upgrade
Haleon PLC Sponsored ADR (HLN) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates --
What Makes Associated British Foods (ASBFY) a New Strong Buy Stock
Investors might want to bet on Associated British Foods PLC (ASBFY), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in
Are You Looking for a Top Momentum Pick? Why Nvidia (NVDA) is a Great Choice
Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the "long context," investors will essentially be "buying high, but hoping to sell
All You Need to Know About JBT (JBTM) Rating Upgrade to Buy
Investors might want to bet on JBT Marel (JBTM), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one


